Skip to content
CompanySight
Company No. 07617346 · Incorporated 28 Apr 2011

Oxford Genetics Ltd

Registered name: OXFORD GENETICS LTD

Part of Avant UK Buyer Limited group

Oxford Genetics Ltd made £2.6m revenue and a £6.1m loss in the year to 31 Dec 2024.

Oxford Genetics Ltd’s revenue fell 72% to £2.6m in the year to 31 Dec 2024, with a loss of £6.1m and 57 employees. The company is classified under “research and experimental development on biotechnology” and is based in London; we hold 3 years of its filed accounts.

Full P&L filedSection M · Professional, scientific and technical activitiesSIC 72110Research and experimental development on biotechnology
Status
Active
Location
London, London
Age
15 yrs · since 2011
Type
Private Limited Company

Part of a group. The filing indicates this company sits within a group structure, so its results may depend on intra-group trading and it may be hard to replicate independently.

Latest accounts · year to 31 Dec 2024

Key figures

Revenue
£2.6m
Growth ▼71.8%
Profit
−£6.1m
Growth —
Profit margin
−236.8%
Gross 73.8%
Employees
57
Change ▼44.7%
Profit / employee
−£107k
Revenue/employee £45.2k
Profitable streak
0yrs
Consecutive profitable years in our data

Badges are automated estimates derived from the filed figures — not statements of fact about the company.

3 filed years

Financial history

Multi-year financials, oldest to newest
Year to31 Dec 202231 Dec 202331 Dec 2024
DisclosureFull P&LFull P&LFull P&L
Profit & loss
Revenue (turnover)£14m£9.1m£2.6m
Cost of sales£2.2m£1.7m£676k
Gross profit£11.9m£7.5m£1.9m
Operating profit−£580k−£2.4m−£5.4m
Profit before tax−£857k−£3.5m−£6.1m
Profit after tax−£1m−£3.6m−£6.1m
Profit (best available)−£1m−£3.6m−£6.1m
Staff costs£7m£5.3m£3.6m
Employees (average)12310357
Ratios
Profit margin−7.2%−39.5%−236.8%
Gross margin84.5%81.7%73.8%
Revenue per employee£114k£88.7k£45.2k
Profit per employee−£8.2k−£35k−£107k
Growth (year on year)
Revenue growth—▼34.9%▼71.8%
Headcount growth—▼16.3%▼44.7%
Balance sheet — indirect signals, not revenue
Cash at bank£3.8m£2.3m£1.1m
Net assets−£3.2m−£7m−£13.1m
Debtors£277k£1.3m£106k
Deferred income£1.1m£1.9m£748k
SourceFullAccounts · bulk data Jun 2024FullAccounts · bulk data Jun 2024FullAccounts · bulk data Oct 2025
Derived from the latest filing

How the business works

Profit margin
−236.8%
Profit ÷ revenue.
Gross margin
73.8%
Gross profit ÷ revenue. High for software and services.
Revenue per employee
£45.2k
Revenue ÷ average employees.
Profit per employee
−£107k
Profit ÷ average employees.
Cash conversion
—
Cash generated from operations ÷ operating profit. Needs a cash-flow statement.
Fixed assets ÷ revenue
—
Capital intensity. Low = capital-light, cheaper to start.
Deferred income ÷ revenue
29%
Customers paying upfront (subscriptions, deposits). Approximate when combined with accruals.
Debtors ÷ revenue
4.1%
Money owed by customers. Low = customers pay quickly.
Indirect — not revenue

Balance-sheet signals

Year-on-year changes in filed balance-sheet items. They can hint at momentum (or investment) but are not revenue or profit and must not be read as such.

Net assets
—
Now −£13.1m
Cash at bank
▼51%
Now £1.1m
Headcount
▼45%
Now 57
Deferred income
▼60%
Now £748k
Fixed assets
—
Now —

Deferred income is reported together with accruals in this filing (“accruals and deferred income”), so it is an approximate signal only.

Corporate ownership

Group structure

Ownership chain

  1. Avant UK Buyer Limitedultimate parent75–100%
  2. Oxford Genetics Ltdthis company

Bands show the share of ownership each company holds in the one below it.

From the Persons with Significant Control register (corporate controllers only).

Same industry, similar size

Similar profitable businesses

Industry benchmarks →

Sources

Latest figures from FullAccounts for the year to 31 Dec 2024 (profit −£6.1m), from the Companies House accounts bulk data published Oct 2025. Spotted an error? Request a correction.

Contains public sector information from Companies House licensed under the Open Government Licence v3.0. Data from Companies House, © Crown copyright. View the licence.